Landscape Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
Landscape Capital Management's IONS Position: Q3 2026 in Review
Landscape Capital Management opened a new position in Ionis Pharmaceuticals (IONS) in Q3 2026: 14,429 shares worth $644K. The stake represents 0.05% of the portfolio and ranks #379 among its holdings. This is a return to the name: Landscape Capital Management previously reported a position in IONS as recently as Q1 2026.
Landscape Capital Management first reported a position in IONS in Q2 2018 and has held it in 10 quarters since. The position peaked at $1.91M in Q4 2025. 458 funds tracked by Wall St. Rank hold IONS as of Q3 2026.
- Landscape Capital Management held 14,429 shares of Ionis Pharmaceuticals worth $644K as of Q3 2026.
- Ionis Pharmaceuticals was a new Landscape Capital Management position in Q3 2026.
- Ionis Pharmaceuticals made up 0.05% of Landscape Capital Management's portfolio in Q3 2026, its #379 holding.
- Landscape Capital Management first reported a position in Ionis Pharmaceuticals in Q2 2018 and has held it in 10 quarters since.
- Landscape Capital Management's Ionis Pharmaceuticals position peaked at $1.91M in Q4 2025.
- 458 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.
Based on Landscape Capital Management's 13F filing for Q3 2026, filed 10 Nov 2026.